 |
Epoetin alfa |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 1993-12-20 00:00:00 |
| Sponsor | Johnson & Johnson Pharmaceutical Research & Dev.,;920 U.S. Highway, Route 202, P.O. Box 300;Raritan, New Jersey, 08869 |
